22NW, LP — 13F Holdings & Portfolio
CIK 1694297 · latest 13F-HR filed 2026-08-14
22NW, LP manages $104.7M in 13F-reported U.S. long-equity assets across 14 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NSP (19.45%), NKTR (18.75%), SRI (17.25%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position and exited 3; 9 existing positions rose in reported value and 2 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 94.6%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 13, 2026.
UNIT C1
SEATTLE, WA 98104
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| 22NW GP, INC. Control | GENERAL PARTNER OF 22NW, LP since Feb 2015 | Less than 5% | Domestic Entity |
| ENGLISH, ARON, REID Control | LIMITED PARTNER since Feb 2015 | 75% or more | Individual |
| STONER, JAMES, PAUL | CFO, CCO since Jul 2018 | Less than 5% | Individual |
| ENGLISH, ARON, REID Control Indirect owner via 22NW GP, INC. | SHAREHOLDER since Feb 2015 | 75% or more | Individual |
Ownership & leadership changes · 4 filings with changes since Jun 12, 2015
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedWAINER, LOUIS, TODD · CFO, CCO · Less than 5% · listed since Feb 2015
- AddedSTONER, JAMES, PAUL · CFO, CCO · Less than 5%
- AddedENGLISH, ARON, REID · SHAREHOLDER · 75% or more · indirect via 22NW GP, INC. · control person
- Listed again22NW GP, INC. · GENERAL PARTNER OF 22NW, LP · Less than 5% · control person
- No longer listed22NW GP, INC. · GP · Less than 5% · control person · listed since Feb 2015
- ChangedWAINER, LOUIS, TODD · title CFO → CFO, CCO
- Listed22NW GP, INC. · GP · Less than 5% · control person
- ListedENGLISH, ARON, REID · LIMITED PARTNER · 75% or more · control person
- ListedWAINER, LOUIS, TODD · CFO · Less than 5%
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- INSPERITY INC$7.0M +52.8%
- STONERIDGE INC$6.1M +51.6%
- REGENXBIO INC$1.8M +43.0%
- REZOLUTE INC$1.8M +70.5%
- CORE MOLDING TECHNOLOGIES IN$1.5M +29.4%
Top Trims
- LIFECORE BIOMEDICAL INC-$18.9M -100.0%
- MINERALYS THERAPEUTICS INC-$9.0M -74.5%
22NW, LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | INSPERITY INC | NSP | 45778Q107 | $20.4M | 19.45% | 493,000 | SH |
| 2 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $19.6M | 18.75% | 281,115 | SH |
| 3 | STONERIDGE INC | SRI | 86183P102 | $18.1M | 17.25% | 2,466,975 | SH |
| 4 | FOX FACTORY HLDG CORP | FOXF | 35138V102 | $11.5M | 10.98% | 678,165 | SH |
| 5 | CORE MOLDING TECHNOLOGIES IN | CMT | 218683100 | $6.5M | 6.17% | 273,521 | SH |
| 6 | REGENXBIO INC | RGNX | 75901B107 | $5.9M | 5.64% | 492,759 | SH |
| 7 | CULP INC | CULP | 230215105 | $5.8M | 5.51% | 1,859,061 | SH |
| 8 | REZOLUTE INC | RZLT | 76200L309 | $4.3M | 4.08% | 820,653 | SH |
| 9 | UNIFI INC | UFI | 904677200 | $4.0M | 3.87% | 852,455 | SH |
| 10 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $3.1M | 2.93% | 113,840 | SH |
| 11 | TEAM INC | TISI | 878155308 | $2.9M | 2.81% | 170,187 | SH |
| 12 | ELEDON PHARMACEUTICALS INC | ELDN | 28617K101 | $2.5M | 2.40% | 636,364 | SH |
| 13 | TURTLE BEACH CORP | TBCH | 900450206 | $179.7K | 0.17% | 14,430 | SH |
| 14 | LIFECORE BIOMEDICAL INC | LFCR | 514766104 | $6.2K | 0.01% | 1,254 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $104.7M | 14 | 0001214659-26-010406 |
| 2026-03-31 | 2026-05-15 | $145.9M | 16 | 0001214659-26-006481 |
| 2025-12-31 | 2026-02-13 | $237.6M | 20 | 0001214659-26-001725 |
| 2025-09-30 | 2025-11-14 | $212.3M | 21 | 0001214659-25-016649 |
SEATTLE, WA 98104